ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 138425 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 138425; 2) Community: the network communities that were significantly associated with the response to NSC 138425; 3) Molecule: the relationships between components within communities and NSC 138425; 4) MDR: the compounds that were significantly associated with the NSC 138425.

NSC Compound Enrichment Correlation
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.000209334878795459 0.29757774
NSC 678994 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- 0.000217933685920731 0.53073061
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.000366080877485931 0.40055436
NSC 631197 9-N-(N'-chloroethyl-N'-ethyl-1,4-diamino-butyl)2-methoxy acridine dihydrochloride 0.000366080877485931 0.52547993
NSC 747651 2-CHLORO-1-NITROSOPYRIDO[3',2':4,5]PYRROLO[1,2-C]BENZOTRIAZINE 0.000366080877485931 0.62919803
NSC 699938 Null 0.000366080877485933 0.61925267
NSC 704113 Null 0.000366080877485933 0.39554627
NSC 328785 ANTINEOPLASTIC-328785 0.000497857311992526 0.38705271
NSC 674067 stereoisomer of NSC 674066-O 0.000497857311992526 0.48843605
NSC 686385 Null 0.000497857311992526 0.4444617
Total:88  Current:2    [First] [Prev] [Next] [Last]